In this online CME self-learning program:
This is a monthly review of select articles in the medical literature pertaining to pharmacotherapy used in
critically ill patient populations. The content below is for information purposes only and is intended to
highlight recent articles that may be of interest to those caring for patients in various intensive care or
related settings. Though some core content from the publications is presented, the reader is encouraged
to review each article in full for additional detail in order to fully interpret the study, its findings, and its
applicability to practice.
This program has been designed for a multidisciplinary physician, nurse, and pharmacist audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is NOT supported by any commercial support.
Release Date: April 24, 2012 -- Expiration Date: April 24, 2014
Faculty: Charles Turck, PharmD, BCPS
By the end of the session the participant will be able to:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through ScientiaCME. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation: ScientiaCME designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™ toward the AMA Physician's Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Disclosures of Faculty / Educational Planners: Charles Turck, PharmD is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from Bayer, Edwards Lifesciences, Eisai, Daiichi-Sankyo, Lilly, Merck, Pfizer, Sanofi Aventis.
Commercial Support Disclosure: This program is NOT supported by any commercial support.
Unlabled Use Disclosure: This program may contain unlabled and/or investigational uses of a commercial product
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.